Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica, Boehringer Ingelheim Strain,Canine Adenovirus Type 2 Virus - Norden Strain,Canine Parainfluenza, 91880 Strain

13 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Bronchiseptica, Boehringer Ingelheim Strain,Canine Adenovirus Type 2 Virus - Norden Strain,Canine Parainfluenza, 91880 Strain. See the species affected, top reactions, and outcomes below.

13
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
3
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Bordetella Bronchiseptica, Boehringer Ingelheim Strain,Canine Adenovirus Type 2 Virus - Norden Strain,Canine Parainfluenza, 91880 Strain

Administration Routes

NasalUnknown

Species Affected

Dog 12
Unknown 1

Most Affected Breeds

Shepherd Dog - German 2
Retriever - Labrador 2
Crossbred Canine/dog 2
Spaniel - King Charles Cavalier 1
Retriever - Golden 1
Shepherd Dog - Australian 1
Shih Tzu 1
Unknown 1
Pit Bull 1
Corgi - Welsh Pembroke 1

Most Reported Reactions

Lack of efficacy - NOS 3
Diarrhoea 3
Laboured breathing 2
Panting 2
Sneezing 2
Abnormal radiograph finding 2
Vomiting 2
Lethargy (see also Central nervous system depression in Neurological) 2
Lack of efficacy (bacteria) - Bordetella 1
Decreased activity 1
Not eating 1
Syncope 1

Outcome Breakdown

Outcome Unknown
7 (58.3%)
Recovered/Normal
3 (25.0%)
Ongoing
2 (16.7%)

Bordetella Bronchiseptica, Boehringer Ingelheim Strain,Canine Adenovirus Type 2 Virus - Norden Strain,Canine Parainfluenza, 91880 Strain Adverse Event Insights

13 reports name Bordetella Bronchiseptica, Boehringer Ingelheim Strain,Canine Adenovirus Type 2 Virus - Norden Strain,Canine Parainfluenza, 91880 Strain; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Bronchiseptica, Boehringer Ingelheim Strain,Canine Adenovirus Type 2 Virus - Norden Strain,Canine Parainfluenza, 91880 Strain. Administration routes: Nasal, Unknown.

By species: Dog (12 reports), Unknown (1 reports). By breed: Shepherd Dog - German (2), Retriever - Labrador (2), Crossbred Canine/dog (2).

Leading clinical signs: Lack of efficacy - NOS (3), Diarrhoea (3), Laboured breathing (2), Panting (2). Outcome, 12 coded reports: Outcome Unknown leads at 58.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.